$LPTH
LIGHTPATH TECHNOLOGIES INC Stock $lpth

$lpth Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000165495423011893 Filed on September 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$8.077M	$9.680M	$32.93M
YoY Change	9.64%	8.68%	-7.38%
Cost Of Revenue	$5.746M	$6.600M	$21.86M
YoY Change	11.93%	8.22%	-7.94%
Gross Profit	$2.332M	$3.080M	$11.07M
YoY Change	4.38%	9.66%	-6.26%
Gross Profit Margin	28.87%	31.82%	33.63%
Selling, General & Admin	$2.661M	$3.010M	$11.44M
YoY Change	0.87%	8.02%	1.92%
% of Gross Profit	114.13%	97.73%	103.27%
Research & Development	$639.9K	$620.0K	$2.145M
YoY Change	16.37%	20.08%	2.86%
% of Gross Profit	27.44%	20.13%	19.37%
Depreciation & Amortization	$810.0K	$810.0K	$3.170M
YoY Change	-0.78%	-5.17%	-12.38%
% of Gross Profit	34.74%	26.3%	28.62%
Operating Expenses	$3.582M	$3.910M	$14.63M
YoY Change	3.26%	9.09%	1.3%
Operating Profit	-$1.251M	-$830.0K	-$3.555M
YoY Change	1.23%	7.02%	35.3%
Interest Expense	$57.61K	-$10.00K	$283.3K
YoY Change	-18.13%	-139.08%	23.44%
% of Operating Profit
Other Income/Expense, Net	-$52.21K	$10.00K	-$258.3K
YoY Change	20.98%	-115.07%	-160.07%
Pretax Income	-$1.303M	-$800.0K	-$3.813M
YoY Change	1.9%	-3.05%	42.31%
Income Tax	$39.55K	$10.00K	$234.0K
% Of Pretax Income
Net Earnings	-$1.342M	-$810.0K	-$4.047M
YoY Change	-2.78%	-40.43%	14.25%
Net Earnings / Revenue	-16.62%	-8.37%	-12.29%
Basic Earnings Per Share	-$0.04		-$0.13
Diluted Earnings Per Share	-$0.04	-$0.02	-$0.13
COMMON SHARES
Basic Shares Outstanding	37.46M shares	37.33M shares	31.64M shares
Diluted Shares Outstanding	37.43M shares		31.64M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.300M	$4.700M	$4.700M
YoY Change	0.03%	-14.67%	-14.67%
Cash & Equivalents	$4.317M	$4.687M	$4.700M
Short-Term Investments
Other Short-Term Assets	$3.100M	$3.100M	$3.100M
YoY Change	613.3%	566.95%	566.95%
Inventory	$7.503M	$7.411M	$7.400M
Prepaid Expenses
Receivables	$5.024M	$6.635M	$6.600M
Other Receivables	$100.0K	$0.00	$0.00
Total Short-Term Assets	$19.97M	$21.76M	$21.80M
YoY Change	21.74%	19.76%	19.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.59M	$12.81M	$22.40M
YoY Change	44.81%	10.06%	1.54%
Goodwill	$8.916M	$5.855M
YoY Change	52.28%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$67.77K	$65.94K	$200.0K
YoY Change	44.0%	-61.38%	17.14%
Total Long-Term Assets	$35.34M	$31.78M	$31.70M
YoY Change	13.69%	-2.36%	-2.59%
TOTAL ASSETS
Total Short-Term Assets	$19.97M	$21.76M	$21.80M
Total Long-Term Assets	$35.34M	$31.78M	$31.70M
Total Assets	$55.31M	$53.54M	$53.50M
YoY Change	16.47%	5.57%	5.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.907M	$2.574M	$2.600M
YoY Change	24.01%	-16.26%	-15.42%
Accrued Expenses	$1.740M	$662.2K	$3.100M
YoY Change	101.33%	18.52%	-14.02%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.400M	$1.100M	$1.100M
YoY Change	25.81%	4.36%	4.36%
Total Short-Term Liabilities	$8.524M	$6.834M	$6.800M
YoY Change	18.88%	-11.64%	-12.07%
LONG-TERM LIABILITIES
Long-Term Debt	$1.237M	$1.551M	$1.900M
YoY Change	-58.06%	-51.82%	-41.18%
Other Long-Term Liabilities	$9.800M	$8.400M	$8.400M
YoY Change	7.52%	-11.37%	-11.37%
Total Long-Term Liabilities	$1.237M	$1.551M	$10.30M
YoY Change	-58.06%	-51.82%	-18.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.524M	$6.834M	$6.800M
Total Long-Term Liabilities	$1.237M	$1.551M	$10.30M
Total Liabilities	$20.42M	$17.58M	$17.60M
YoY Change	3.37%	-16.2%	-16.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$209.2M	-$207.8M
YoY Change	1.95%	1.99%
Common Stock	$374.6K	$373.4K
YoY Change	-99.84%	-99.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$34.89M	$35.95M	$36.00M
YoY Change
Total Liabilities & Shareholders Equity	$55.31M	$53.54M	$53.50M
YoY Change	16.47%	5.57%	5.49%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$1.342M	-$810.0K	-$4.047M
YoY Change	-2.78%	-40.43%	14.25%
Depreciation, Depletion And Amortization	$810.0K	$810.0K	$3.170M
YoY Change	-0.78%	-5.17%	-12.38%
Cash From Operating Activities	$1.140M	-$1.890M	-$2.810M
YoY Change	-374.46%	-270.01%	-291.89%
INVESTING ACTIVITIES
Capital Expenditures	$955.0K	$750.0K	$3.077M
YoY Change	292.37%	-659.95%	89.18%
Acquisitions
YoY Change
Other Investing Activities	-$210.0K	$140.0K	$210.0K
YoY Change
Cash From Investing Activities	-$1.162M	-$610.0K	-$2.868M
YoY Change	377.6%	355.43%	76.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$9.200M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$213.9K	-70.00K	$7.456M
YoY Change	14.3%	-66.89%	-1271.99%
NET CHANGE
Cash From Operating Activities	$1.140M	-1.890M	-$2.810M
Cash From Investing Activities	-$1.162M	-610.0K	-$2.868M
Cash From Financing Activities	-$213.9K	-70.00K	$7.456M
Net Change In Cash	-$284.5K	-2.570M	$1.637M
YoY Change	-76.47%	-435.34%	-229.19%
FREE CASH FLOW
Cash From Operating Activities	$1.140M	-$1.890M	-$2.810M
Capital Expenditures	$955.0K	$750.0K	$3.077M
Free Cash Flow	$185.0K	-$2.640M	-$5.887M
YoY Change	-128.08%	-311.93%	3522.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5507891	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	21859126	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	23744524	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000889971
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	44500000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37344739	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27046790	shares
CY2023	lpth	Total Deferred TotalDeferred	-73000	usd
CY2023Q2	lpth	Total Deferred Tax Assets TotalDeferredTaxAssets	1291000	usd
CY2022Q2	lpth	Unpaid Withholding Tax UnpaidWithholdingTax	40000	usd
CY2022	lpth	Granted Shares GrantedShares	125000	shares
CY2022	lpth	Balance Ending Shares Unexercisable And Unvested BalanceEndingSharesUnexercisableAndUnvested	138260	shares
CY2023	lpth	Balance Ending Shares Unexercisable And Unvested BalanceEndingSharesUnexercisableAndUnvested	396202	shares
CY2023	lpth	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P10M24D
CY2022	lpth	Weighted Average Remaining Contract Life Unexercisable Balance Ending WeightedAverageRemainingContractLifeUnexercisableBalanceEnding	P10M24D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	897398	shares
CY2023Q2	lpth	Total Unrecognized Compensation Cost TotalUnrecognizedCompensationCost	776000	usd
CY2022Q2	lpth	Accrued Liability AccruedLiability	430000	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-27548
CY2023	dei	Entity Registrant Name EntityRegistrantName	LIGHTPATH TECHNOLOGIES, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-0708398
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2603 Challenger Tech Court
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32826
CY2023	dei	City Area Code CityAreaCode	407
CY2023	dei	Local Phone Number LocalPhoneNumber	382-4003
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.01
CY2023	dei	Trading Symbol TradingSymbol	LPTH
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	31945187	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37455438	shares
CY2023	dei	Auditor Firm AuditorFirmId	569
CY2023	dei	Auditor Name AuditorName	MSL, P.A.
CY2023	dei	Auditor Location AuditorLocation	Orlando, Florida
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4687004	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18502	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36313	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	6634574	usd
CY2022Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	5211292	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	140000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	143000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	65939	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	27737	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	44500000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37344739	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27046790	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	270468	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	232315003	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	935125	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203789358	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	29731238	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50713921	usd
CY2023	us-gaap	Revenues Revenues	32933949	usd
CY2022	us-gaap	Revenues Revenues	35559160	usd
CY2023	us-gaap	Gross Profit GrossProfit	11074823	usd
CY2022	us-gaap	Gross Profit GrossProfit	11814636	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11437241	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11221866	usd
CY2023	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	2145413	usd
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	2085686	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1125083	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1125083	usd
CY2023	us-gaap	Gain Loss On Disposition Of Other Financial Assets GainLossOnDispositionOfOtherFinancialAssets	78373	usd
CY2022	us-gaap	Gain Loss On Disposition Of Other Financial Assets GainLossOnDispositionOfOtherFinancialAssets	-9235	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	14629364	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	14441870	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3554541	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2627234	usd
CY2023	us-gaap	Interest Expense InterestExpense	283266	usd
CY2022	us-gaap	Interest Expense InterestExpense	229475	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	24970	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	177435	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-258296	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-52040	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3812837	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2679274	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	234034	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	862907	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-4046871	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-3542181	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-328589	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1181027	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-4375460	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-4723208	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31637445	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27019534	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	31637445	shares
CY2022	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	27019534	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	33577485	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	51711	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	825250	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1181027	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3542181	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	29731238	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	40380	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	45900	usd
CY2023	lpth	Issuance Of Common Stock Under Public Equity Placement Amount IssuanceOfCommonStockUnderPublicEquityPlacementAmount	9199510	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1310957	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-328589	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4046871	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-4046871	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-3542181	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3174569	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3617743	usd
CY2023	lpth	Interest From Amortization Of Debt Costs InterestFromAmortizationOfDebtCosts	58774	usd
CY2022	lpth	Interest From Amortization Of Debt Costs InterestFromAmortizationOfDebtCosts	51974	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-78373	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9235	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1310957	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	825250	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8158	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7713	usd
CY2023	lpth	Increase Decrease In Operating Lease Assets And Liabilities IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities	-231561	usd
CY2022	lpth	Increase Decrease In Operating Lease Assets And Liabilities IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities	-222047	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	316297	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	456538	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-73015	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	545015	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1431440	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-562651	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	137103	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-741604	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1217622	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-97792	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10560	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-977622	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1087746	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2809523	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1464128	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3077154	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1626614	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	209169	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2867985	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1626614	usd
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	40380	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	51711	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9199510	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	61223	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	141245	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	266850	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	1852256	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	681301	usd
CY2023	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	73003	usd
CY2022	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	212211	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7455876	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-636174	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-141769	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-468143	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1636599	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1266803	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5507891	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6774694	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7144490	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5507891	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	221773	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	157407	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	428914	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	267585	usd
CY2023	lpth	Purchase Of Equipment Through Finance Lease Arrangements PurchaseOfEquipmentThroughFinanceLeaseArrangements	451048	usd
CY2022	lpth	Purchase Of Equipment Through Finance Lease Arrangements PurchaseOfEquipmentThroughFinanceLeaseArrangements	0	usd
CY2023	lpth	Equipment Deposit Paid In Restricted Stock EquipmentDepositPaidInRestrictedStock	45900	usd
CY2022	lpth	Equipment Deposit Paid In Restricted Stock EquipmentDepositPaidInRestrictedStock	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0in; text-align:justify;"><strong><em>Management estimates.</em></strong>Management makes estimates and assumptions during the preparation of the Company’s Consolidated Financial Statements that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Such estimates and assumptions could change in the future as more information becomes available, which, in turn, could impact the amounts reported and disclosed herein.</p>
CY2023	us-gaap	Inventory For Long Term Contracts Or Programs Description InventoryForLongTermContractsOrProgramsDescription	The Company looks at the following criteria for parts to consider for the inventory allowance: (i) items that have not been sold in two years and (ii) items that have not been purchased in two years. These items, as identified, are allowed for at 100%, as well as allowing 50% for other items deemed to be slow moving within the last twelve months and allowing 25% for items deemed to have low material usage within the last six months. Items of which we have greater than a two-year supply are also reserved at 25% to 100%, depending on usage rates.
CY2023Q2	lpth	Cash And Cash Equivalent At Carrying Value CashAndCashEquivalentAtCarryingValue	7100000	usd
CY2023	us-gaap	Foreign Earnings Repatriated ForeignEarningsRepatriated	1900000	usd
CY2022	us-gaap	Foreign Earnings Repatriated ForeignEarningsRepatriated	2800000	usd
CY2023Q2	lpth	Retained Earning Accumulated Deficit RetainedEarningAccumulatedDeficit	2900000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	303235	usd
CY2023	us-gaap	Revenues Revenues	32933949	usd
CY2022	us-gaap	Revenues Revenues	35559160	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	314063	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	307034	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	317892	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	316000	usd
CY2022	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	457000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29430398	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27376704	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16619468	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15736241	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12810930	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11640463	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10676000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10676000	usd
CY2023Q2	lpth	Intangible Assets Net IntangibleAssetsNet	3332715	usd
CY2022Q2	lpth	Intangible Assets Net IntangibleAssetsNet	3332715	usd
CY2023Q2	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	55000000	shares
CY2023Q2	lpth	Common Stock Share Authorized CommonStockShareAuthorized	50000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	lpth	Preferred Stock Share Authorized PreferredStockShareAuthorized	5000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3812837	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2679274	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3799	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3829	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-76000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	541015	usd
CY2022	lpth	Total Deferred TotalDeferred	545015	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	234034	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	862907	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-800696	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-562648	usd
CY2023	lpth	Net Foreign Income Subject To Lower Tax Rate NetForeignIncomeSubjectToLowerTaxRate	-396742	usd
CY2022	lpth	Net Foreign Income Subject To Lower Tax Rate NetForeignIncomeSubjectToLowerTaxRate	-297049	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-303366	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-159950	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3331277	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1255273	usd
CY2023	lpth	Income Tax Reconciliation Nol Expiration And Adjustments IncomeTaxReconciliationNOLExpirationAndAdjustments	4015752	usd
CY2022	lpth	Income Tax Reconciliation Nol Expiration And Adjustments IncomeTaxReconciliationNOLExpirationAndAdjustments	2550645	usd
CY2023	lpth	Income Tax Reconciliation Gilti IncomeTaxReconciliationGILTI	192452	usd
CY2022	lpth	Income Tax Reconciliation Gilti IncomeTaxReconciliationGILTI	138611	usd
CY2023	lpth	Income Tax Reconciliation Federal Research And Development And Other Credits IncomeTaxReconciliationFederalResearchAndDevelopmentAndOtherCredits	491112	usd
CY2022	lpth	Income Tax Reconciliation Federal Research And Development And Other Credits IncomeTaxReconciliationFederalResearchAndDevelopmentAndOtherCredits	-121990	usd
CY2023	lpth	Income Tax Reconciliation Stockbased Compensation IncomeTaxReconciliationStockbasedCompensation	-34976	usd
CY2022	lpth	Income Tax Reconciliation Stockbased Compensation IncomeTaxReconciliationStockbasedCompensation	20472	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-57762	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	11387	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	459537	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	538702	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	234034	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	862907	usd
CY2021Q2	lpth	Cash Saving Due To Utilization Of Payroll Tax Deferral CashSavingDueToUtilizationOfPayrollTaxDeferral	325000	usd
CY2023	lpth	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rates EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates	0.25	pure
CY2023	us-gaap	Dividends Dividends	1900000	usd
CY2022	us-gaap	Dividends Dividends	2800000	usd
CY2023	lpth	Chinese Withholding Tax Paid ChineseWithholdingTaxPaid	210000	usd
CY2022	lpth	Chinese Withholding Tax Paid ChineseWithholdingTaxPaid	280000	usd
CY2023	lpth	Associated Income Tax Expense AssociatedIncomeTaxExpense	210000	usd
CY2022	lpth	Associated Income Tax Expense AssociatedIncomeTaxExpense	208000	usd
CY2023Q2	lpth	Unpaid Withholding Tax UnpaidWithholdingTax	40000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.20	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1877458	shares
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064	pure
CY2023Q2	lpth	Stock Offering Price StockOfferingPrice	75800000	usd
CY2023Q2	lpth	A Common Stock Offering Price ACommonStockOfferingPrice	25200000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9243000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12197277	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	340000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	536000	usd
CY2023Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1787000	usd
CY2022Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2279000	usd
CY2023Q2	lpth	Deferred Tax Assets Capitalized Rd Expenses DeferredTaxAssetsCapitalizedRDExpenses	763000	usd
CY2022Q2	lpth	Deferred Tax Assets Capitalized Rd Expenses DeferredTaxAssetsCapitalizedRDExpenses	371000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	200000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	263973	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	15000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	267000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12348000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15914250	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11057000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14388277	usd
CY2022Q2	lpth	Total Deferred Tax Assets TotalDeferredTaxAssets	1525973	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	740000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	763988	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	876000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1160000	usd
CY2023Q2	lpth	Total Deferred Tax Liabilities TotalDeferredTaxLiabilities	1616000	usd
CY2022Q2	lpth	Total Deferred Tax Liabilities TotalDeferredTaxLiabilities	1923988	usd
CY2023Q2	lpth	Net Deferred Tax Asset NetDeferredTaxAsset	-325000	usd
CY2022Q2	lpth	Net Deferred Tax Asset NetDeferredTaxAsset	-398015	usd
CY2023	lpth	Future Taxable Income FutureTaxableIncome	37000000	usd
CY2023	lpth	Valuation Adjustment Against Deferred Tax Asset ValuationAdjustmentAgainstDeferredTaxAsset	11100000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3300000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	140000	usd
CY2023	lpth	Maximum Number Of Shares Empolyee Can Purchase MaximumNumberOfSharesEmpolyeeCanPurchase	8000	shares
CY2023	lpth	Offering Period OfferingPeriod	P12M
CY2023	lpth	Number Of Common Purcase Within Offering Period NumberOfCommonPurcaseWithinOfferingPeriod	4000	shares
CY2023	lpth	Discount Of Purchase Of Common Stock DiscountOfPurchaseOfCommonStock	4000	usd
CY2022	lpth	Discount Of Purchase Of Common Stock DiscountOfPurchaseOfCommonStock	5000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	7615625	shares
CY2023Q2	lpth	Share Based Compensation Arrangement By Share Based Payment Award Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber	2232417	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.808	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0209	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y9M
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	432927	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.01
CY2022	lpth	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P8Y9M18D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1761885	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y10M24D
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.02
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	368461	shares
CY2022	lpth	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms	P1Y2M12D
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	45143	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	23465	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.67
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	5534	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	534462	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.03
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2079669	shares
CY2022	lpth	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms2 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms2	P0Y10M24D
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	611386	shares
CY2023	lpth	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Rsa ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedRSA	246942	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	1068291	shares
CY2023	lpth	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Rsa ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedRSA	-145209	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	26542	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.03
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1596222	shares
CY2023	lpth	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms2 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms2	P1Y1M6D
CY2023	lpth	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number Rsa ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumberRSA	101733	shares
CY2023	lpth	Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualtermsrestricted Stock Award SharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualtermsrestrictedStockAward	P0Y8M12D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.96
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y9M18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	938817	shares
CY2023	lpth	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Rsa ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumberRSA	0	shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.21
CY2023	lpth	Weighted Average Remaining Contract Life Unexercisable Balance Ending1 WeightedAverageRemainingContractLifeUnexercisableBalanceEnding1	P7Y1M6D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	657405	shares
CY2023	lpth	Weighted Average Remaining Contract Life Unexercisable Balance Ending WeightedAverageRemainingContractLifeUnexercisableBalanceEnding	P1Y1M6D
CY2023	lpth	Weighted Average Remaining Contract Life Unexercisable Restricted Share Award Balance Ending WeightedAverageRemainingContractLifeUnexercisableRestrictedShareAwardBalanceEnding	101733	shares
CY2023	lpth	Weighted Average Remaining Contract Life Unexercisable Rsa Contract Balance Ending WeightedAverageRemainingContractLifeUnexercisableRSAContractBalanceEnding	P0Y8M12D
CY2023Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	55000	sqft
CY2023Q2	lpth	Share Based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amount ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmount	128081	usd
CY2023Q2	lpth	Employee Service Share Based Compensation Restricted Stock Award EmployeeServiceShareBasedCompensationRestrictedStockAward	80462	usd
CY2023Q2	lpth	Share Based Payment Arrangements Nonvested Award Cost Not Yet Recognized Amount ShareBasedPaymentArrangementsNonvestedAwardCostNotYetRecognizedAmount	567000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	775543	usd
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	920571	shares
CY2021Q2	lpth	Share Based Compensation Arrangement By Share Based Payment Award Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedWeightedAverageGrantDateFairValue	1.59
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	493461	shares
CY2022	lpth	Share Based Compensation Arrangement By Share Based Payment Awards Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardsGrantsInPeriodWeightedAverageGrantDateFairValue	1.74
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	335519	shares
CY2022	lpth	Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodWeightedAverageGrantDateFairValue	1.42
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	14501	shares
CY2022	lpth	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Cancelled Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedCancelledForfeitedWeightedAverageGrantDateFairValue	1.97
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1064012	shares
CY2022Q2	lpth	Share Based Compensation Arrangement By Share Based Payment Award Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedWeightedAverageGrantDateFairValue	1.71
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	858328	shares
CY2023	lpth	Share Based Compensation Arrangement By Share Based Payment Awards Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardsGrantsInPeriodWeightedAverageGrantDateFairValue	1.24
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	998400	shares
CY2023	lpth	Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodWeightedAverageGrantDateFairValue	1.52
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	26542	shares
CY2023	lpth	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Cancelled Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedCancelledForfeitedWeightedAverageGrantDateFairValue	0
CY2023Q2	lpth	Share Based Compensation Arrangement By Share Based Payment Award Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedWeightedAverageGrantDateFairValue	1.40
CY2023	lpth	Description Of Lease DescriptionOfLease	expiring in 2024 to 2034
CY2023	lpth	Lease Term LeaseTerm	P12M
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	2574401	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	1023814	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1550587	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1310957	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	825250	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4046871	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3542181	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31637445	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27019534	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31637445	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27019534	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2547738	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2390134	shares
CY2023	lpth	Description Of Plan DescriptionOfPlan	Under the Insperity Plan, the Company matched 100% of the first 2% of employee contributions. Effective February 24, 2023, all plan assets were transferred to the LightPath Technologies Inc. 401(k) plan (the “LightPath Plan”). The LightPath Plan is adefined 401(k) contribution plan, administered by a third party, that all U.S. employees, over the age of 21, are eligible to participate in after three months of employment. Under the LightPath Plan, the Company matches 100% of the first 2% of employee contributions. As of June 30, 2023, there were 57 employees enrolled in this plan
CY2023	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	121000	usd
CY2022	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	123000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	875454	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	668054	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	71326	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	162057	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7590	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	19571	usd
CY2023	lpth	Total Finance Lease Cost TotalFinanceLeaseCost	78916	usd
CY2022	lpth	Total Finance Lease Cost TotalFinanceLeaseCost	181628	usd
CY2023	us-gaap	Lease Cost LeaseCost	954370	usd
CY2022	us-gaap	Lease Cost LeaseCost	849682	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9571604	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10420604	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	542105	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	61566	usd
CY2023Q2	lpth	Right Of Use Asset RightOfUseAsset	10113709	usd
CY2022Q2	lpth	Right Of Use Asset RightOfUseAsset	10482170	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	969890	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	965622	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	103646	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	55348	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8393248	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9478077	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	341201	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	11454	usd
CY2023Q2	lpth	Total Lease Liabilities TotalLeaseLiabilities	9807985	usd
CY2022Q2	lpth	Total Lease Liabilities TotalLeaseLiabilities	10510501	usd
CY2023Q2	lpth	Finance Lease Rights Of Use Asset Accumulated Amortization FinanceLeaseRightsOfUseAssetAccumulatedAmortization	72000	usd
CY2022Q2	lpth	Finance Lease Rights Of Use Asset Accumulated Amortization FinanceLeaseRightsOfUseAssetAccumulatedAmortization	418000	usd
CY2023	lpth	Weighted Average Remaining Lease Term In Years Operating Leases WeightedAverageRemainingLeaseTermInYearsOperatingLeases	P9Y2M12D
CY2023	lpth	Weighted Average Remaining Lease Term In Years Finance Leases WeightedAverageRemainingLeaseTermInYearsFinanceLeases	P4Y6M
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.029	pure
CY2023	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	1020992	usd
CY2022	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	638943	usd
CY2023	lpth	Finance Lease Payments Use FinanceLeasePaymentsUse	7590	usd
CY2022	lpth	Finance Lease Payments Use FinanceLeasePaymentsUse	16070	usd
CY2023	lpth	Financing Cash Used For Finance Leases FinancingCashUsedForFinanceLeases	73003	usd
CY2022	lpth	Financing Cash Used For Finance Leases FinancingCashUsedForFinanceLeases	172344	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	128828	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1025294	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	117016	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1167096	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	94701	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1140297	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	85144	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1169757	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	85144	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1200291	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	5583700	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	510833	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11286435	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	65986	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1923297	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	444847	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	9363138	usd
CY2023Q2	lpth	Security Interest Amount SecurityInterestAmount	2457000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1023814	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1413499	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	79761	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	37571	usd
CY2023Q2	lpth	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	19756	usd
CY2023Q2	lpth	Offering Price Decreasing OfferingPriceDecreasing	50600000	usd
CY2023Q2	lpth	Cash Cash Equivalents And Restricted Cash CashCashEquivalentsAndRestrictedCash	0.25	pure
CY2021	us-gaap	Payments For Fees PaymentsForFees	718000	usd
CY2022	us-gaap	Payments For Fees PaymentsForFees	400000	usd
CY2021Q2	lpth	Accrued Liability AccruedLiability	210000	usd
CY2021	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	485000	usd
CY2023Q2	lpth	Cumulative Gain CumulativeGain	607000	usd
CY2022Q2	lpth	Cumulative Gain CumulativeGain	935000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	37000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	3000	usd
CY2023	us-gaap	Revenues Revenues	32933949	usd
CY2022	us-gaap	Revenues Revenues	35559160	usd
CY2023Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	31776093	usd
CY2022Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	32544507	usd
CY2023	lpth	Aggregate Annual Revenue AggregateAnnualRevenue	0.24	pure
CY2023	lpth	Aggregate Accounts Receivable AggregateAccountsReceivable	0.25	pure
CY2022	lpth	Aggregate Annual Revenue AggregateAnnualRevenue	0.35	pure
CY2022	lpth	Aggregate Accounts Receivable AggregateAccountsReceivable	0.13	pure
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	140000	usd

Files In Submission

Name	View Source	Status
0001654954-23-011893-index-headers.html	Edgar Link	pending
0001654954-23-011893-index.html	Edgar Link	pending
0001654954-23-011893.txt	Edgar Link	pending
0001654954-23-011893-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lpth-20230630.xsd	Edgar Link	pending
lpth_10k.htm	Edgar Link	pending
lpth-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lpth-20230630_def.xml	Edgar Link	unprocessable
lpth-20230630_lab.xml	Edgar Link	unprocessable
lpth-20230630_pre.xml	Edgar Link	unprocessable
lpth_10k_htm.xml	Edgar Link	completed
lpth_ex211.htm	Edgar Link	pending
lpth_ex231.htm	Edgar Link	pending
lpth_ex24.htm	Edgar Link	pending
lpth_ex311.htm	Edgar Link	pending
lpth_ex312.htm	Edgar Link	pending
lpth_ex321.htm	Edgar Link	pending
lpth_ex322.htm	Edgar Link	pending
lpth_ex41.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LPTH
LIGHTPATH TECHNOLOGIES INC Stock $lpth

2023 Q3 Form 10-K Financial Statement

#000165495423011893 Filed on September 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LPTH LIGHTPATH TECHNOLOGIES INC Stock $lpth

2023 Q3 Form 10-K Financial Statement

#000165495423011893 Filed on September 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LPTH
LIGHTPATH TECHNOLOGIES INC Stock $lpth